Pablo Martí-Rodrigo

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 4

Top Topics

Estrogen Receptor

Cell Cycle Arrest

Cross Sectional

Top Venues

Nature communications

Molecular oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Sara Rojas-Vázquez, Beatriz Lozano-Torres, Alba García-Fernández, Irene Galiana, Ana Perez-Villalba, Pablo Martí-Rodrigo, M José Palop, Marcia Domínguez, Mar Orzáez, Félix Sancenón, Juan F Blandez, Isabel Fariñas, Ramón Martínez-Máñez
A renal clearable fluorogenic probe for in vivo β-galactosidase activity detection during aging and senolysis. Nature communications 15 (1) (2024)
Sara Rojas-Vázquez, Beatriz Lozano-Torres, Alba García-Fernández, Irene Galiana, Ana Perez-Villalba, Pablo Martí-Rodrigo, M José Palop, Marcia Domínguez, Mar Orzáez, Félix Sancenón, Juan F Blandez, Isabel Fariñas, Ramón Martínez-Máñez
A renal clearable fluorogenic probe for in vivo β-galactosidase activity detection during aging and senolysis. Nature communications 15 (1) (2024)
Daniela Hühn, Pablo Martí-Rodrigo, Silvana Mouron, Catherine Hansel, Kirsten Tschapalda, Bartlomiej Porebski, Maria Häggblad, Louise Lidemalm, Miguel Quintela-Fandino, Jordi Carreras-Puigvert, Oscar Fernandez-Capetillo
Prolonged estrogen deprivation triggers a broad immunosuppressive phenotype in breast cancer cells. Molecular oncology (2021)
Alberto Marti-Rodrigo, Fernando Alegre, Ángela B Moragrega, Francisco García-García, Pablo Martí-Rodrigo, Anabel Fernández-Iglesias, Jordi Gracia-Sancho, Nadezda Apostolova, Juan V Esplugues, Ana Blas-Garcia
Rilpivirine attenuates liver fibrosis through selective STAT1-mediated apoptosis in hepatic stellate cells. Gut 69 (5) (2019)